Literature DB >> 12089660

Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.

Scott E Kellerman1, Katherine McCombs, Marsha Ray, Wendy Baughman, Michael W Reeves, Tanja Popovic, Nancy E Rosenstein, Monica M Farley, Paul Blake, David S Stephens.   

Abstract

Carriage of Neisseria meningitidis in a Georgia county with hypersporadic incidence of meningococcal disease ("hypersporadic county") and in a county with no cases of meningococcal disease was determined by a cross-sectional pharyngeal culture study of high school students. Among 2730 students from whom culture samples were obtained, meningococcal carriage was 7.7% (140/1818) in the hypersporadic county and 6.1% (56/912) in the comparison county. Carriage rates by serogroup and genetic type (i.e., electrophoretic type [ET]) did not differ significantly between counties, but apartment or mobile home residency was a risk factor for carriage in the hypersporadic county. Although most cases of meningococcal disease in the hypersporadic county were caused by members of the serogroup C ET-37 clonal group, no ET-37 meningococcal isolates were recovered from carriers in this county. However, 38% of all meningococcal isolates recovered from carriers in both counties were members of the serogroup Y ET-508 clonal group, an emerging cause of meningococcal disease in Georgia and throughout the United States during 1996-2001. Shifts in carriage and transmission of meningococcal strains with different pathogenic potential are important determinants of meningococcal disease incidence.

Entities:  

Mesh:

Year:  2002        PMID: 12089660     DOI: 10.1086/341067

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Biofilm formation by Neisseria meningitidis.

Authors:  Kyungcheol Yi; Andrew W Rasmussen; Seshu K Gudlavalleti; David S Stephens; Igor Stojiljkovic
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z.

Authors:  Désirée E Bennett; Robert M Mulhall; Mary T Cafferkey
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 4.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

6.  Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.

Authors:  Jane W Marsh; Kathleen A Shutt; Rolando Pajon; Mary M Tulenko; Stephen Liu; Rosemary A Hollick; Julia A Kiehlbauch; Thomas A Clark; David S Stephens; Kathryn E Arnold; Robert A Myers; Leonard W Mayer; Lee H Harrison
Journal:  Vaccine       Date:  2011-06-24       Impact factor: 3.641

7.  Meningococcal carriage among Georgia and Maryland high school students.

Authors:  Lee H Harrison; Kathleen A Shutt; Kathryn E Arnold; Eric J Stern; Tracy Pondo; Julia A Kiehlbauch; Robert A Myers; Rosemary A Hollick; Susanna Schmink; Marianne Vello; David S Stephens; Nancy E Messonnier; Leonard W Mayer; Thomas A Clark
Journal:  J Infect Dis       Date:  2014-12-11       Impact factor: 5.226

8.  Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

9.  Meningococcal carriage during a clonal meningococcal B outbreak in France.

Authors:  V Delbos; L Lemée; J Bénichou; G Berthelot; M-K Taha; F Caron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-02       Impact factor: 3.267

10.  Meningococcal disease: changes in epidemiology and prevention.

Authors:  Qiuzhi Chang; Yih-Ling Tzeng; David S Stephens
Journal:  Clin Epidemiol       Date:  2012-09-19       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.